Peters GR - Search Results

1

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

Girgis IG, Patel MR, Peters GR, Moore KT, Mahaffey KW, Nessel CC, Halperin JL, Califf RM, Fox KA, Becker RC. Girgis IG, et al. Among authors: peters gr. J Clin Pharmacol. 2014 Aug;54(8):917-27. doi: 10.1002/jcph.288. Epub 2014 Mar 26. J Clin Pharmacol. 2014. PMID: 24668660 Free article. Clinical Trial.

2

Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants.

Nnane IP, Plotnikov AH, Peters G, Johnson M, Kojak C, Vutikullird A, Ariyawansa J, De Vries R, Davies BE. Nnane IP, et al. Clin Pharmacokinet. 2016 Feb;55(2):225-36. doi: 10.1007/s40262-015-0309-8. Clin Pharmacokinet. 2016. PMID: 26242382 Clinical Trial.

3

Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis.

Wilson SJ, Connolly TM, Peters G, Ghosh A, Johnson M, Newby DE. Wilson SJ, et al. Cardiovasc Res. 2019 Mar 1;115(3):669-677. doi: 10.1093/cvr/cvy227. Cardiovasc Res. 2019. PMID: 30184110 Free PMC article. Clinical Trial.

4

Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe?

Tranter E, Peters G, Boyce M, Warrington S. Tranter E, et al. Br J Clin Pharmacol. 2013 Aug;76(2):164-72. doi: 10.1111/bcp.12096. Br J Clin Pharmacol. 2013. PMID: 23438102 Free PMC article. Review.

5

The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.

Nathan PJ, Watson J, Lund J, Davies CH, Peters G, Dodds CM, Swirski B, Lawrence P, Bentley GD, O'Neill BV, Robertson J, Watson S, Jones GA, Maruff P, Croft RJ, Laruelle M, Bullmore ET. Nathan PJ, et al. Int J Neuropsychopharmacol. 2013 May;16(4):721-31. doi: 10.1017/S1461145712000752. Epub 2012 Aug 29. Int J Neuropsychopharmacol. 2013. PMID: 22932339 Free article. Clinical Trial.

6

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW Jr; EXULT A Study Group. Francis CW, et al. Among authors: peters gr. N Engl J Med. 2003 Oct 30;349(18):1703-12. doi: 10.1056/NEJMoa035162. N Engl J Med. 2003. PMID: 14585938 Free article. Clinical Trial.

7

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW. Colwell CW Jr, et al. Among authors: peters gr. J Thromb Haemost. 2003 Oct;1(10):2119-30. doi: 10.1046/j.1538-7836.2003.00368.x. J Thromb Haemost. 2003. PMID: 14521593 Free article. Clinical Trial.

8

No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran.

Sarich TC, Teng R, Peters GR, Wollbratt M, Homolka R, Svensson M, Eriksson UG. Sarich TC, et al. Among authors: peters gr. Clin Pharmacokinet. 2003;42(5):485-92. doi: 10.2165/00003088-200342050-00006. Clin Pharmacokinet. 2003. PMID: 12739986 Clinical Trial.

9

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW Jr. Francis CW, et al. Among authors: peters gr. Ann Intern Med. 2002 Oct 15;137(8):648-55. doi: 10.7326/0003-4819-137-8-200210150-00008. Ann Intern Med. 2002. PMID: 12379064 Clinical Trial.

10

Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.

Fleishaker JC, Pearson LK, Pearson PG, Wienkers LC, Hopkins NK, Peters GR. Fleishaker JC, et al. Among authors: peters gr. J Clin Pharmacol. 1999 Mar;39(3):260-7. J Clin Pharmacol. 1999. PMID: 10073325 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page